🇦🇪 Reyvow in United Arab Emirates

Reyvow (LASMIDITAN) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Status: likely_approved

Reyvow in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United Arab Emirates

Frequently asked questions

Is Reyvow approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Reyvow in United Arab Emirates?

Eli Lilly is the originator. The local marketing authorisation holder may differ — check the official source linked above.